Low Incidence of GVHD with T-Cell Depleted Allografts Facilitate Further Treatments for Post-Transplantation Relapse in AML and MDS

Similar Items

• CD34+ selection vs. reduced-intensity conditioning and unmodified graft for allogeneic hematopoietic cell transplantation in patients with AML and MDS > 50 years
  od: Barba, Pere, i dr.
  Izdano: (2018)
• End-of-Life Care for Older AML Patients Relapsing after Allogeneic Stem Cell Transplant at a Dedicated Cancer Center
  od: Lin, Richard J., i dr.
  Izdano: (2018)
• Fludarabine-Melphalan Conditioning for AML and MDS: Alemtuzumab Reduces Acute and Chronic GVHD without Affecting Long-Term Outcomes
  od: Van Besien, Koen, i dr.
  Izdano: (2009)
• Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia, Normal Cytogenetics, and the FLT3-ITD Mutation
  od: Berman, Ellin, i dr.
  Izdano: (2015)
• Ex Vivo T Cell Depleted versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission
  od: Bayraktar, Ulas D., i dr.
  Izdano: (2013)